ENNATURE3 hours ago
Ennature Bio Pharma Limited Lists on NSE and BSE: Biopharma Division Reports Rs 246 Crore in FY26 Revenue
Ennature Bio Pharma Limited lists on NSE and BSE, reporting Rs 246 crore in FY26 revenue, driven by growth in branded nutraceuticals.
